PHIO PHARMACEUTICALS CORP.

PHIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Feb 6, 2024 AMENDMENT NO. 4 TO SCHEDULE 13G
8-K Jan 26, 2024 FORM 8-K
424B3 Dec 28, 2023 424B3
EFFECT Dec 27, 2023
CORRESP Dec 22, 2023
UPLOAD Dec 21, 2023
S-1 Dec 19, 2023 REGISTRATION STATEMENT
D Dec 19, 2023
8-K Dec 8, 2023 CURRENT REPORT
8-K Nov 9, 2023 CURRENT REPORT
10-Q Nov 9, 2023 FORM 10-Q FOR SEPT 2023
4 Oct 3, 2023 FORM 4 SUBMISSION
S-8 Sep 29, 2023 FORM S-8
8-K Aug 21, 2023 FORM 8-K
8-K Aug 10, 2023 CURRENT REPORT
10-Q Aug 10, 2023 QUARTERLY REPORT
8-K Jul 26, 2023 FORM 8-K
4 Jul 5, 2023 FORM 4 SUBMISSION
424B3 Jun 20, 2023 424B3
EFFECT Jun 16, 2023
4 Jun 15, 2023 FORM 4 SUBMISSION
CORRESP Jun 14, 2023
UPLOAD Jun 14, 2023
D Jun 13, 2023
ARS Jun 9, 2023 ANNUAL REPORT TO SECURITY HOLDERS
← Newer Page 8 of 36 · 884 filings Older →